USPTO serial 50186951
OCULIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with OCULIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of central nervous system diseases and conditions; Pharmaceutical preparations in the nature of liquid solutions for the treatment of ophthalmic diseases of humans; Eye drops for medical and pharmaceutical purposes; Topical drug formulation for ophthalmic use; Pharmaceutical preparations for the neuroprotective treatment of optic neuritis; Pharmaceutical preparations for the treatment of non-arteritic anterior ischemic optic neuropathy | ACTIVE | — |
| 042 | (Based on Use) Research and development of pharmaceutical products and medicines addressing ophthalmic and neuro-ophthalmic conditions; Research and development of pharmaceutical preparations for the treatment of eye diseases and conditions; Laboratory research services in the field of eye diseases and conditions; Laboratory research services in the field of ophthalmic and neuro-ophthalmic conditions (Based on Intent to Use) Research and development of pharmaceutical preparations for the treatment of central nervous system diseases and conditions; Laboratory research services in the field of central nervous system diseases and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2026 | NWAP | NEW APPLICATION ENTERED | — |